However, we did not find important differences between the analyzed SLE subcohorts in terms of VEGF concentrations, disease duration, inflammatory markers, activity scores, or other atherosclerosis indices like ABI and HRI, so we decided not to exclude those patients from the analysis. This evidence concerns the gene VEGFA and systemic lupus erythematosus.